The lead compounds may help the scientists for the rational designing of an innovative class of drug candidates targeting enzyme-based diseases.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:The discovery of enzyme targeting inhibitors is a popular area of drug research.
📊
Key Findings & Data:Biological activities of the compounds bearing phenol and heteroaryl groups make them popular groups in drug design targeting important enzymes such as acetylcholinesterase (AChE, E.C.3.1.1.7) and carbonic anhydrases (CAs, EC 4.2.1.1). 1-(4-hydroxyphenyl)- 2-((aryl)thio)ethanones as possible AChE and CAs inhibitors were synthesized, and their chemical structures were confirmed by IR, $^{1} H NMR, ^{13} C NMR$, and HRMS.
💡
Conclusion & Impact:The lead compounds may help the scientists for the rational designing of an innovative class of drug candidates targeting enzyme-based diseases.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
The discovery of enzyme targeting inhibitors is a popular area of drug research. Biological activities of the compounds bearing phenol and heteroaryl groups make them popular groups in drug design targeting important enzymes such as acetylcholinesterase (AChE, E.C.3.1.1.7) and carbonic anhydrases (CAs, EC 4.2.1.1). 1-(4-hydroxyphenyl)- 2-((aryl)thio)ethanones as possible AChE and CAs inhibitors were synthesized, and their chemical structures were confirmed by IR, $^{1} H NMR, ^{13} C NMR$, and HRMS. The compounds 2 and 4 were found potent AChE inhibitors with the Ki values of 22.13 ±1.96 nM and 23.71 ±2.95 nM, respectively, while the compounds 2 (Ki = 8.61 ±0.90 nM, on hCA I) and 1 (Ki = 8.76 ±0.84 nM, on hCA II) had considerable CAs inhibitory potency. The lead compounds may help the scientists for the rational designing of an innovative class of drug candidates targeting enzyme-based diseases.
🔖
Cite This Article
DEMİR, Y., GÜLÇİN, İ., KAZAZ, C., YAMALI, C., GÜL, H. İ. (2022). Synthesis and bioactivities of 1-(4-hydroxyphenyl)-2-((heteroaryl)thio)ethanones as carbonic anhydrase I, II and acetylcholinesterase inhibitors. Turkish Journal of Chemistry, Cilt: 44 - Sayı: 4, 1058–1067. https://ajindex.com/articles/601619
Stasiuk M, Bartosiewicz D, Kozubek A. Inhibitory effect of some natural and semisynthetic phenolic lipids upon acetylcholinesterase activity. Food Chemistry 2008
108 (3): 996-1001. doi: 10.1016/j.foodchem.2007.12.011 2. Bytyqi-Damoni A, Kestane A, Taslimi P, Tuzun B, Zengin M et al. Novel carvacrol based new oxypropanolamine derivatives: design, synthesis, characterization, biological evaluation, and molecular docking studies. Journal of Molecular Structure 2020
1202 (2020): 127297. doi: 10.1016/j.molstruc.2019.127297 3. Yamali C, Gul HI, Kazaz C, Levent S, Gulcin I. Synthesis, structure elucidation, and in vitro pharmacological evaluation of novel polyfluoro substituted pyrazoline type sulfonamides as multi-target agents for inhibition of acetylcholinesterase and carbonic anhydrase I and II enzymes. Bioorganic Chemistry 2020
96 (2020): 103627. doi: 10.1016/j.bioorg.2020.103627 4. Li G, Hong G, Li X, Zhang Y, Xu Z et al. Synthesis and activity towards Alzheimer’s disease in vitro: tacrine, phenolic acid and ligustrazine hybrids. European Journal of Medicinal Chemistry 2018
doi: 10.1016/j.ejmech.2018.01.028 5. El-Sayed NA, Farag AE, Ezzat MAF, Akincioglu H, Gülçin İ et al. Design, synthesis, in vitro and in vivo evaluation of novel pyrrolizine-basedcompounds with potential activity as cholinesterase inhibitors and anti-Alzheimer’s agents. Bioorganic Chemistry 2019
103312. doi: 10.1016/j.bioorg.2019.103312 6. Tripathi PN, Srivastava P, Sharma P, Seth A, Shrivastava SK. Design and development of novel N -(pyrimidin2-yl)-1,3,4-oxadiazole hybrids to treat cognitive dysfunctions. Bioorganic and Medicinal Chemistry 2019
27 (7): 1327-1340. doi: 10.1016/j.bmc.2019.02.031 7. Yin L, Wang L, Liu XJ, Cheng FC, Shi DH et al. Synthesis and bioactivity of novel C2-glycosyl triazole derivatives as acetylcholinesterase inhibitors. Heterocyclic Communications 2017
23 (3): 231-236. doi: 10.1515/hc-2016-0163 8. Mehrun N, Munawar MA, Chattha FA, Kousar S, Munir J et al. Synthesis of novel triazoles and a tetrazole of escitalopram as cholinesterase inhibitors. Bioorganic and Medicinal Chemistry 2015
23 (17): 6014-6024. doi: 10.1016/j.bmc.2015.06.051 9. Acar Cevik U, Saglik BN, Levent S, Osmaniye D, Kaya Cavuşoglu B et al. Synthesis and AChE-inhibitory activity of new benzimidazole derivatives. Molecules 2019
24 (5): 861-878. doi: 10.3390/molecules24050861 10. Ivanova L, Karelson M, Dobchev DA. Multitarget approach to drug candidates against Alzheime